NIOSH List of Hazardous Drugs in Healthcare Settings, 2024

Details

• Alternative Title:
  NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2024
• Personal Author:
  Connor, Thomas H. ; DeBord, D. Gayle ; MacKenzie, Barbara A. ; O'Callaghan, James P. ; Ovesen, Jerald L. ; Sammons, Deborah ; Trout, Douglas B. ; Whittaker, Christine
• Corporate Authors:
  National Institute for Occupational Safety and Health
• Description:
  Supersedes the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 [DHHS (NIOSH) Publication Number 2016-161]. The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). The 2004 list was updated in 2010, 2012, 2014, and 2016. The current update (2024) adds 25 drugs to the 2016 List, 12 with manufacturer’s special handling information (MSHI), and removed 7 drugs from the 2016 List. The drugs reviewed for this update were either newly approved or received new safety-related warnings from the FDA between January 2014 and December 2015. Also added to the NIOSH 2024 List were recently approved drugs with MSHI through May 2023 that had been previously announced. [Description provided by NIOSH]
  
  To see the list of updates since the publicaiton of this document, refer to the Notice table on the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 webpage https://www.cdc.gov/niosh/docs/2025-103/.
  
  
• Subjects:
  Antineoplastic Agents / Poisoning Hazardous Substances Health Care Facilities Workforce And Services Health Personnel Occupational Exposure / Prevention & Control Occupational Health Respiratory Tract Diseases Safety
• Keywords:
  Antineoplastic Agents Hazardous Drugs Hazards Health Care Facilities Health Care Personnel
• Series:
  NIOSH Numbered Publications
• Subseries:
  Technical Report
• DOI:
  https://doi.org/10.26616/NIOSHPUB2025103
• Publisher:
  National Institute for Occupational Safety and Health
• Document Type:
  Text
• Genre:
  Report
• Place as Subject:
  Chicago Region [OSHA] ; Ohio ; Philadelphia Region [OSHA] ; West Virginia
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  DSI - Division of Science Integration ; HELD - Health Effects Laboratory Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  40 pdf pages
• NIOSHTIC Number:
  nn:20070409
• Citation:
  NIOSH [2024]. NIOSH list of hazardous drugs in healthcare settings, 2024. By Ovesen JL, Sammons D, Connor TH, MacKenzie BA, DeBord DG, Trout DB, O’Callaghan JP, Whittaker C. Cincinnati, OH: U.S. Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2025-103 (Supersedes 2016-161), https://doi.org/10.26616/NIOSHPUB2025103
• Federal Fiscal Year:
  2025
• Peer Reviewed:
  False
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:90ed9729ac206fff534a6bdafa7f843d0cdac59eb1b69b7844b3c5f36b95fbc1ee5e09c630c81bb0bcc1b17fbb2493774ff3affabb7e7e333fb42babe2248ff6
• Download URL:
  https://stacks.cdc.gov/view/cdc/210278/cdc_210278_DS1.pdf
• File Type:
  [PDF - 359.72 KB ]